Pablo D. Becker

ORCID: 0000-0003-1980-1230
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Immunotherapy and Immune Responses
  • T-cell and B-cell Immunology
  • Immune Cell Function and Interaction
  • HIV Research and Treatment
  • Monoclonal and Polyclonal Antibodies Research
  • CAR-T cell therapy research
  • vaccines and immunoinformatics approaches
  • Immune Response and Inflammation
  • Cancer Immunotherapy and Biomarkers
  • Virus-based gene therapy research
  • Research on Leishmaniasis Studies
  • Trypanosoma species research and implications
  • Influenza Virus Research Studies
  • Hepatitis B Virus Studies
  • Renal cell carcinoma treatment
  • Respiratory viral infections research
  • Hepatitis C virus research
  • Pneumonia and Respiratory Infections
  • Pancreatic function and diabetes
  • Cancer-related Molecular Pathways
  • RNA Interference and Gene Delivery
  • interferon and immune responses
  • Poxvirus research and outbreaks
  • Bone Metabolism and Diseases
  • Xenotransplantation and immune response

Guy's Hospital
2015-2021

King's College London
2011-2021

London Cancer
2020-2021

University College London
1997-2021

Medical Research Council
2015-2020

Cancer Research UK
2020

CRUK Lung Cancer Centre of Excellence
2020

Kings Health Partners
2015-2020

Helmholtz Centre for Infection Research
2005-2014

W. L. Gore & Associates (Germany)
2013

Significance The design of effective T-cell vaccines against pathogens and tumor antigens is challenged by the highly inefficient identification subset peptides from a given antigen that effectively stimulate an immune response. Here we report relative hydrophobicity receptor contact residues markedly enriched in immunogenic major histocompatibility complex class I epitopes both human murine MHCs, self pathogen-derived epitopes. Incorporating into epitope prediction models increases...

10.1073/pnas.1500973112 article EN Proceedings of the National Academy of Sciences 2015-03-23
Lewis Au Emine Hatipoglu Marc Robert de Massy Kevin Litchfield Gordon Beattie and 95 more Andrew Rowan Désirée Schnidrig R. Houston Thompson Fiona Byrne Stuart Horswell Nicos Fotiadis Steve Hazell David Nicol Scott T.C. Shepherd Annika Fendler Robert M. Mason Lyra Del Rosario Kim Edmonds Karla Lingard Sarah Sarker Mary Mangwende Eleanor Carlyle Jan Attig Kroopa Joshi Imran Uddin Pablo D. Becker Mariana Werner Sunderland Ayse U. Akarca Ignazio Puccio William Yang Tom Lund Kim Dhillon Marcos Duran Vasquez Ehsan Ghorani Hang Xu Charlotte Spencer José I. López Anna Green Ula Mahadeva Elaine Borg Miriam Mitchison David A. Moore Ian Proctor Mary Falzon Lisa Pickering Andrew J.S. Furness James L. Reading Roberto Salgado Teresa Marafioti Mariam Jamal‐Hanjani George Kassiotis Benny Chain James Larkin Charles Swanton Sergio A. Quezada Samra Turajlic Chris Abbosh Kai‐Keen Shiu John Bridgewater Daniel Hochhauser Martin Förster SM Lee Tanya Ahmad Dionysis Papadatos-Pastos Sam M. Janes Peter Van Loo Katey S.S. Enfield Nicholas McGranahan Ariana Huebner Stephan Beck Peter J. Parker Henning Walczak Tariq Enver Robert E. Hynds Ron Sinclair Chi-wah Lok Zoe Rhodes David A. Moore Reena Khiroya Giorgia Trevisan Peter Ellery Mark Linch Sebastian Brandner Crispin T. Hiley Selvaraju Veeriah Maryam Razaq Heather Shaw G. Attard Mita Afroza Akther Cristina Naceur‐Lombardelli Lizi Manzano Maise Al-Bakir Simranpreet Summan Nnenna Kanu Sophia Ward Uzma Asghar Emilia L. Lim Faye Gishen Adrian Tookman Paddy Stone

ADAPTeR is a prospective, phase II study of nivolumab (anti-PD-1) in 15 treatment-naive patients (115 multiregion tumor samples) with metastatic clear cell renal carcinoma (ccRCC) aiming to understand the mechanism underpinning therapeutic response. Genomic analyses show no correlation between molecular features and response, whereas ccRCC-specific human endogenous retrovirus expression indirectly correlates clinical T receptor (TCR) analysis reveals significantly higher number expanded TCR...

10.1016/j.ccell.2021.10.001 article EN cc-by Cancer Cell 2021-10-28
Ehsan Ghorani James L. Reading Jake Y. Henry Marc Robert de Massy Rachel Rosenthal and 95 more Virginia Turati Kroopa Joshi Andrew J.S. Furness Assma Ben Aïssa Sunil Kumar Saini Sofie Ramskov Andrew Georgiou Mariana Werner Sunderland Yien Ning Sophia Wong Maria Vila de Mucha William Day Felipe Gálvez‐Cancino Pablo D. Becker Imran Uddin Theres Oakes Mazlina Ismail Tahel Ronel Annemarie Woolston Mariam Jamal‐Hanjani Selvaraju Veeriah Nicolai J. Birkbak Gareth A. Wilson Kevin Litchfield Lucía Conde José Afonso Guerra‐Assunção Kevin Blighe Dhruva Biswas Roberto Salgado Tom Lund Maise Al Bakir David A. Moore Crispin T. Hiley Sherene Loi Yuxin Sun Yinyin Yuan Khalid AbdulJabbar Samra Turajilic Javier Herrero Tariq Enver Sine Reker Hadrup Allan Hackshaw Karl S. Peggs Nicholas McGranahan Benny Chain Charles Swanton Mariam Jamal‐Hanjani Karl S. Peggs Andrew Georgiou Mariana Werner Sunderland James L. Reading Sergio A. Quezada Ehsan Ghorani Marc Robert de Massy David A. Moore Allan Hackshaw Nicholas McGranahan Rachel Rosenthal Selvaraju Veeriah Dhruva Biswas Crispin T. Hiley Benny Chain Gareth A. Wilson Nicolai J. Birkbak Maise Al Bakir Kevin Litchfield Javier Herrero Roberto Salgado Yenting Ngai Abigail Sharp Cristina Rodrigues Oliver Pressey Sean Smith Nicole Gower Harjot Kaur Dhanda David Lawrence Sophia Ward Nikolaos Panagiotopoulos Robert S. George Davide Patrini Mary Falzon Elaine Borg Reena Khiroya Asia Ahmed Magali N. Taylor Junaid Choudhary Penny Shaw Sam M. Janes Martin Förster Tanya Ahmad SM Lee Dawn Carnell R. Mendes Jeremy George Neal Navani Marco Scarci

10.1038/s43018-020-0066-y article EN Nature Cancer 2020-05-22

Stabilization of virus protein structure and nucleic acid integrity is challenging yet essential to preserve the transcriptional competence live recombinant viral vaccine vectors in absence a cold chain. When coupled with needle-free skin delivery, such platform would address an unmet need global coverage against HIV other pathogens. Herein, we show that simple dissolvable microneedle array (MA) delivery system preserves immunogenicity vaccines encoded by human adenovirus type 5 (rAdHu5)....

10.1073/pnas.1214449110 article EN Proceedings of the National Academy of Sciences 2013-02-05

Immunosuppressive drugs in clinical transplantation are necessary to inhibit the immune response donor antigens. Although they effective controlling acute rejection, do not prevent long-term transplant loss from chronic rejection. In addition, immunosuppressive have adverse side effects, including increased rate of infections and malignancies. Adoptive cell therapy with human Tregs represents a promising strategy for induction tolerance. Phase I/II trials transplanted patients already...

10.3324/haematol.2015.128934 article EN cc-by-nc Haematologica 2015-10-15

A novel subset of human regulatory B-cells has recently been described. They arise from within the transitional B-cell subpopulation and are characterised by production IL-10. appear to be significant importance in regulating T-cell immunity vivo. Despite this important function, molecular mechanisms which they control activation incompletely defined. Here we show that produced more IL-10 expressed higher levels receptor after CD40 engagement compared other subsets. Furthermore, under...

10.1038/srep20044 article EN cc-by Scientific Reports 2016-01-22

Programmed cell death protein 1 (PD-1) is expressed on T cells upon receptor (TCR) stimulation. PD-1 ligand (PD-L1) in most tumor environments, and its binding to drives them apoptosis or into a regulatory phenotype. The fact that PD-L1 itself also activation has been largely neglected. Here, we demonstrate ligation human CD25-depleted CD4 + cells, combined with CD3/TCR stimulation, induces their conversion highly suppressive cells. Furthermore, this effect was prominent memory (CD45RA −...

10.1371/journal.pbio.3001199 article EN cc-by PLoS Biology 2021-04-26

ABSTRACT To stimulate both local and systemic immune responses against Trypanosoma cruzi , Salmonella enterica serovar Typhimurium aroA was exploited as a DNA delivery system for cruzipain (SCz). In murine model we compared SCz alone (GI) or coadministered with carrying plasmid encoding granulocyte-macrophage colony-stimulating factor (GII), well protocols in which priming followed by boosting recombinant (rCz) admixed either CpG-ODN (GIII) MALP-2, synthetic derivative of...

10.1128/iai.01163-07 article EN Infection and Immunity 2007-10-29

Cytokine immunotherapies targeting T lymphocytes are attractive clinical interventions against viruses and tumors. In the mouse, homeostasis of memory α/β CD8 + cells natural killer (NK) is significantly improved with increased IL-15 bioavailability. contrast, role “transpresented” on human T-cell development in vivo unknown. We found that both CD4 immune system (HIS) mice highly sensitive to transpresented vivo, naïve (CD62L CD45RA ) phenotype − CD45RO subsets being following “boosting.”...

10.1073/pnas.1019167108 article EN Proceedings of the National Academy of Sciences 2011-03-28

Background Passive transfer of antibodies not only provides immediate short-term protection against disease, but also can be exploited as a therapeutic tool. However, the 'humanization' murine monoclonal (mAbs) is time-consuming and expensive process that has inherent drawback potentially altering antigenic specificity and/or affinity. The immortalization human B cells represents an alternative for obtaining mAbs, relies on availability biological samples from vaccinated individuals or...

10.1371/journal.pone.0013137 article EN cc-by PLoS ONE 2010-10-04

The superoxide-generating enzyme Nox2 contributes to hypertension and cardiovascular remodeling triggered by activation of the renin-angiotensin system. Multiple Nox2-expressing cells are implicated in angiotensin II-induced (Ang II-induced) pathophysiology, but importance leukocyte subsets is poorly understood. Here, we investigated role T cells, particularly Tregs. Mice globally deficient displayed increased numbers Tregs heart at baseline, whereas Ang effector cell (Teff) infiltration was...

10.1172/jci97490 article EN cc-by Journal of Clinical Investigation 2018-04-24

Abstract The macrophage-activating lipopeptide-2 (MALP-2) is an agonist of the TLR heterodimer 2/6, which exhibits potent activity as mucosal adjuvant, promoting strong humoral and cellular responses. Although B cells expressing TLR2/6 are potential targets, very little known about effect MALP-2 on cells. Studies were performed using total spleen or purified from WT mice animals deficient in TLR2, T cells, specific subpopulations They demonstrated that promotes a cell-independent activation...

10.4049/jimmunol.174.10.6308 article EN The Journal of Immunology 2005-05-15

There is an increasing body of evidence suggesting that the transfer preformed MHC class I:peptide complexes between a virus-infected cell and uninfected APC, termed cross-dressing, represents important mechanism Ag presentation to CD8+ T cells in host defense. However, although it has been shown memory can be activated by dendritic (DCs) cross-dressed from parenchymal cells, unknown whether conditions exist during virus infection which naive are primed differentiate cytolytic effectors...

10.4049/jimmunol.1200664 article EN The Journal of Immunology 2012-07-22

Numerical and functional defects in plasmacytoid dendritic cells (pDCs) are an important hallmark of progressive HIV-1 infection, yet its etiology remains obscure. p17 matrix protein (p17) modulates a variety cellular responses, biological activity depends on the expression receptors (p17Rs) surface target cells. In this study, we show that peripheral blood pDCs express p17Rs their freshly isolated sensitive to stimulation. Upon treatment, undergo phenotypic differentiation with...

10.1073/pnas.0800370105 article EN Proceedings of the National Academy of Sciences 2008-03-01

Abstract B cells have been reported to promote graft rejection through alloantibody production. However, there is growing evidence that can contribute the maintenance of tolerance. Here, we used a mouse model MHC-class I mismatched skin transplantation investigate contribution survival. We demonstrate adoptive transfer prolongs survival but only when were isolated from mice housed in low sterility “conventional” (CV) facilities and not pathogen free (SPF). prolongation was lost IL-10...

10.1038/srep11554 article EN cc-by Scientific Reports 2015-06-25

The generation of tissue resident memory (TRM) cells at the body surfaces to provide a front line defence against invading pathogens represents an important goal in vaccine development for wide variety pathogens. It has been widely assumed that local delivery mucosae is necessary achieve aim. Here we characterise novel micro-needle array (MA) system fabricated deliver live recombinant human adenovirus type 5 vector (AdHu5) encoding HIV-1 gag. We demonstrate rapid dissolution kinetics...

10.1016/j.jconrel.2017.10.026 article EN cc-by Journal of Controlled Release 2017-10-19
Coming Soon ...